Trial intelligence / Profile preview

Effects of Paracetamol and Caffeine on Cognitive Function in Common Cold

NCT01686646Phase 3Completed

Sponsor
GSK
Start
Nov 2011
Primary completion
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of caffeine in common cold, sponsored by GSK. Started Nov 2011; status: completed.

02

Drugs

caffeine
03

Conditions

common cold

Beyond the preview

Go deeper on NCT01686646.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01686646.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call